LOC101928718: A Potential Drug Target for Cancer, Autoimmune, and Neurodegenerative Diseases

LOC101928718: A Potential Drug Target for Cancer, Autoimmune, and Neurodegenerative Diseases

LOC101928718 is a protein that is expressed in various tissues throughout the body. It is a part of the T-cell receptor signaling pathway, which is a critical pathway that regulates the immune system. The T-cell receptor signaling pathway is a well-established drug target, and LOC101928718 is a potential drug target for several diseases.

LOC101928718 is a transmembrane protein that is characterized by its extracellular domain. It consists of a single transmembrane domain and an intracellular tail region. The transmembrane domain of LOC101928718 is rich in conserved features, such as a putative transmembranespanning region (TMSR) and a carboxy-terminal region (CTR), which are involved in the formation of a tight interaction between the protein and the cell membrane.

The intracellular tail region of LOC101928718 is characterized by a conserved coiled-coil structure. This region plays a critical role in the regulation of protein stability and localization to the cell surface.

LOC101928718 is a protein that is expressed in various tissues throughout the body, including the skin, the gut, the lungs, and the liver. It is also expressed in the placenta, which is a vital organ that plays a critical role in the development and maintenance of the fetus. The expression of LOC101928718 in the placenta suggests that it may be involved in the regulation of fetal growth and development.

In addition to its expression in the placenta, LOC101928718 is also expressed in various other tissues, including the brain, the heart, and the kidneys. This suggests that it may be involved in the regulation of multiple physiological processes that are critical to human health.

The T-cell receptor signaling pathway is a well-established drug target, and LOC101928718 is a potential drug target for several diseases. The T-cell receptor signaling pathway is involved in the regulation of immune system function, and LOC101928718 is a key component of this pathway.

LOC101928718 is a potential drug target for several diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. For example, LOC101928718 has been shown to be involved in the regulation of cancer cell growth and survival. Additionally, LOC101928718 has been shown to be involved in the regulation of autoimmune diseases, such as rheumatoid arthritis and type 1 diabetes.

In addition to its potential role in the regulation of autoimmune diseases, LOC101928718 may also be involved in the regulation of neurodegenerative diseases. For example, LOC101928718 has been shown to be involved in the regulation of the aggregation of beta-amyloid peptides, which are a hallmark of neurodegenerative diseases such as Alzheimer's disease.

LOC101928718 is a protein that is expressed in various tissues throughout the body and is involved in the regulation of the T-cell receptor signaling pathway. It is a potential drug target for several diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. Further research is needed to determine the full role of LOC101928718 in these diseases and to develop effective therapies that target this protein.

Protein Name: Uncharacterized LOC101928718

The "LOC101928718 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101928718 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804 | LOC101928816 | LOC101928824 | LOC101928832 | LOC101928834 | LOC101928844 | LOC101928847 | LOC101928849 | LOC101928859 | LOC101928861 | LOC101928864 | LOC101928890 | LOC101928893 | LOC101928894 | LOC101928911 | LOC101928912 | LOC101928923 | LOC101928940 | LOC101928947 | LOC101928948 | LOC101928950 | LOC101928972 | LOC101929003 | LOC101929048 | LOC101929073 | LOC101929085 | LOC101929098 | LOC101929106 | LOC101929129 | LOC101929130 | LOC101929133 | LOC101929174 | LOC101929200 | LOC101929208 | LOC101929219 | LOC101929237 | LOC101929256 | LOC101929258 | LOC101929268 | LOC101929279 | LOC101929298 | LOC101929309 | LOC101929372 | LOC101929401 | LOC101929418 | LOC101929419 | LOC101929439 | LOC101929452 | LOC101929457 | LOC101929460 | LOC101929470 | LOC101929485 | LOC101929491 | LOC101929506 | LOC101929532 | LOC101929536 | LOC101929551 | LOC101929555 | LOC101929563 | LOC101929578 | LOC101929615 | LOC101929622 | LOC101929633 | LOC101929698 | LOC101929707 | LOC101929710 | LOC101929713 | LOC101929718 | LOC101929727 | LOC101929755 | LOC101929761 | LOC101929762 | LOC101929772 | LOC101929788 | LOC101929996 | LOC101930053 | LOC101930071 | LOC101930098 | LOC101930112 | LOC101930129 | LOC101930496 | LOC102723311 | LOC102723313 | LOC102723321 | LOC102723323 | LOC102723340 | LOC102723341 | LOC102723342 | LOC102723345 | LOC102723364 | LOC102723370 | LOC102723376 | LOC102723403 | LOC102723409 | LOC102723439 | LOC102723446